RPRX 03:31 PM EDT, 05/03/2013 (MidnightTrader) -- Repros Therapeutics Inc. (RPXC) was downgraded to Neutral from Overweight by analysts at JPMorgan Chase. The firm currently has a price target of $16 on the stock. RPRX is down 3.8% at $18.96, near the high in a 52-week range of $4.12 - $20.78. Price: 18.96, Change: -0.75, Percent Change: -3.8 http://www.midnighttrader.com (C) 1999-2013 MT Newswires, a Division of MidnightTrader, Inc. All rights reserved.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.